Colgate-Palmolive
Market Cap
US$63.1b
Last Updated
2020/07/13 06:41 UTC
Data Sources
Company Financials +
Executive Summary
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide.
Rewards
Risk Analysis
Snowflake Analysis
Established dividend payer with acceptable track record.
Similar Companies
Share Price & News
How has Colgate-Palmolive's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: CL has not had significant price volatility in the past 3 months.
Market Performance
7 Day Return
0.3%
CL
2.6%
US Household Products
2.3%
US Market
1 Year Return
-0.4%
CL
10.2%
US Household Products
6.7%
US Market
Return vs Industry: CL underperformed the US Household Products industry which returned 10.2% over the past year.
Return vs Market: CL underperformed the US Market which returned 6.7% over the past year.
Shareholder returns
| CL | Industry | Market | |
|---|---|---|---|
| 7 Day | 0.3% | 2.6% | 2.3% |
| 30 Day | 1.2% | 7.8% | 6.0% |
| 90 Day | 0.8% | 9.4% | 18.9% |
| 1 Year | 2.0%-0.4% | 13.0%10.2% | 9.0%6.7% |
| 3 Year | 8.5%1.5% | 55.5%42.8% | 36.6%27.7% |
| 5 Year | 22.2%8.7% | 79.5%54.9% | 64.2%46.1% |
Price Volatility Vs. Market
How volatile is Colgate-Palmolive's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 months ago | Simply Wall St
An Intrinsic Calculation For Colgate-Palmolive Company (NYSE:CL) Suggests It's 21% Undervalued3 months ago | Simply Wall St
Colgate-Palmolive Company (NYSE:CL) Is Yielding 2.8% - But Is It A Buy?4 months ago | Simply Wall St
What Type Of Shareholder Owns Colgate-Palmolive Company's (NYSE:CL)?Valuation
Is Colgate-Palmolive undervalued compared to its fair value and its price relative to the market?
14.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CL ($73.68) is trading below our estimate of fair value ($85.76)
Significantly Below Fair Value: CL is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: CL is good value based on its PE Ratio (25.1x) compared to the US Household Products industry average (31.8x).
PE vs Market: CL is poor value based on its PE Ratio (25.1x) compared to the US market (16.2x).
Price to Earnings Growth Ratio
PEG Ratio: CL is poor value based on its PEG Ratio (12x)
Price to Book Ratio
PB vs Industry: CL has negative assets, so we can't compare its PB Ratio to the US Household Products industry average.
Next Steps
Future Growth
How is Colgate-Palmolive forecast to perform in the next 1 to 3 years based on estimates from 16 analysts?
2.1%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CL's forecast earnings growth (2.1% per year) is below the savings rate (2.2%).
Earnings vs Market: CL's earnings (2.1% per year) are forecast to grow slower than the US market (22.9% per year).
High Growth Earnings: CL's earnings are forecast to grow, but not significantly.
Revenue vs Market: CL's revenue (2% per year) is forecast to grow slower than the US market (9.4% per year).
High Growth Revenue: CL's revenue (2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CL's Return on Equity is forecast to be very high in 3 years time (172.9%).
Next Steps
Past Performance
How has Colgate-Palmolive performed over the past 5 years?
-1.0%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CL has high quality earnings.
Growing Profit Margin: CL's current net profit margins (15.9%) are higher than last year (15.1%).
Past Earnings Growth Analysis
Earnings Trend: CL's earnings have declined by -1% per year over the past 5 years.
Accelerating Growth: CL's earnings growth over the past year (8.5%) exceeds its 5-year average (-1% per year).
Earnings vs Industry: CL earnings growth over the past year (8.5%) underperformed the Household Products industry 14.2%.
Return on Equity
High ROE: Whilst CL's Return on Equity (784.46%) is outstanding, this metric is skewed due to their high level of debt.
Next Steps
Financial Health
How is Colgate-Palmolive's financial position?
Financial Position Analysis
Short Term Liabilities: CL's short term assets ($4.2B) do not cover its short term liabilities ($4.4B).
Long Term Liabilities: CL's short term assets ($4.2B) do not cover its long term liabilities ($10.3B).
Debt to Equity History and Analysis
Debt Level: CL's debt to equity ratio (2108.5%) is considered high.
Reducing Debt: CL's debt to equity ratio has increased from 830.4% to 2108.5% over the past 5 years.
Debt Coverage: CL's debt is well covered by operating cash flow (45.8%).
Interest Coverage: CL's interest payments on its debt are well covered by EBIT (26x coverage).
Balance Sheet
Next Steps
Dividend
What is Colgate-Palmolive current dividend yield, its reliability and sustainability?
2.39%
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CL's dividend (2.39%) is higher than the bottom 25% of dividend payers in the US market (1.68%).
High Dividend: CL's dividend (2.39%) is low compared to the top 25% of dividend payers in the US market (4.6%).
Stability and Growth of Payments
Stable Dividend: CL's dividends per share have been stable in the past 10 years.
Growing Dividend: CL's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (58.5%), CL's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: CL's dividends in 3 years are forecast to be covered by earnings (59.1% payout ratio).
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.5yrs
Average management tenure
CEO
Noel Wallace (56yo)
1.25yrs
Tenure
US$10,828,665
Compensation
Mr. Noel R. Wallace serves as Chief Executive Officer and Director of Colgate-Palmolive Company since April 2, 2019 and has been its President since July 11, 2018. Mr. Wallace serves as Chairman of Colgate ...
CEO Compensation Analysis
Compensation vs Market: Noel's total compensation ($USD10.83M) is about average for companies of similar size in the US market ($USD11.50M).
Compensation vs Earnings: Noel's compensation has increased by more than 20% in the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 1.25yrs | US$10.83m | 0.027% $16.9m | |
| Chief Financial Officer | 2.17yrs | US$3.48m | 0.0050% $3.2m | |
| Chief Legal Officer & Secretary | 5.67yrs | US$2.96m | 0.0036% $2.3m | |
| Group President of Latin America & Asia Pacific | 0.92yr | US$2.95m | 0.0053% $3.3m | |
| Group President of Global Innovation Group & Africa-Eurasia | 0.92yr | US$3.02m | 0.0016% $1.0m | |
| Chief Technology Officer | no data | no data | 0.0065% $4.1m | |
| Chief Information Officer | no data | no data | no data | |
| Chief Investor Relations Officer | no data | no data | no data | |
| Vice President of Global Ethics & Compliance | 1.5yrs | no data | no data | |
| VP & Chief Communications Officer | 1.92yrs | no data | no data | |
| Corporate Officer & Chief Human Resources Officer | 0.50yr | no data | 0.0014% $858.3k | |
| Senior VP & Chief of Staff | 4.5yrs | no data | 0.010% $6.4m |
1.5yrs
Average Tenure
60yo
Average Age
Experienced Management: CL's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 1.25yrs | US$10.83m | 0.027% $16.9m | |
| Lead Independent Director | no data | US$319.03k | 0.0030% $1.9m | |
| Independent Director | 14.75yrs | US$303.48k | 0.0027% $1.7m | |
| Independent Director | 4.33yrs | US$290.48k | 0.0011% $694.2k | |
| Independent Director | 1.33yrs | US$236.48k | 0.00041% $258.7k | |
| Independent Director | 4.83yrs | US$290.36k | 0.00010% $63.1k | |
| Independent Director | 6.08yrs | US$295.36k | 0.0020% $1.3m | |
| Independent Director | 0.33yr | no data | 0.00019% $119.9k | |
| Independent Director | 5.33yrs | US$295.48k | 0.00055% $347.1k | |
| Independent Director | 10.33yrs | US$295.48k | 0.0029% $1.8m |
4.8yrs
Average Tenure
61.5yo
Average Age
Experienced Board: CL's board of directors are considered experienced (4.8 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Colgate-Palmolive Company's company bio, employee growth, exchange listings and data sources
Key Information
- Name: Colgate-Palmolive Company
- Ticker: CL
- Exchange: NYSE
- Founded: 1806
- Industry: Household Products
- Sector: Household
- Market Cap: US$63.109b
- Shares outstanding: 856.53m
- Website: https://www.colgatepalmolive.com
Number of Employees
Location
- Colgate-Palmolive Company
- 300 Park Avenue
- New York
- New York
- 10022
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| CL | NYSE (New York Stock Exchange) | Yes | Common Stock | US | USD | Jan 1968 |
| 0P59 | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Jan 1968 |
| 919477 | SWX (SIX Swiss Exchange) | Yes | Common Stock | CH | CHF | Jan 1968 |
| CPA | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Jan 1968 |
| CL * | BMV (Bolsa Mexicana de Valores) | Yes | Common Stock | MX | MXN | Jan 1968 |
| CPA | XTRA (XETRA Trading Platform) | Yes | Common Stock | DE | EUR | Jan 1968 |
| CPA | ETLX (Eurotlx) | Yes | Common Stock | IT | EUR | Jan 1968 |
| COLG | WBAG (Wiener Boerse AG) | Yes | Common Stock | AT | EUR | Jan 1968 |
| CL | BASE (Buenos Aires Stock Exchange) | CEDEAR EACH 3 REP 1 ORD USD1 | AR | ARS | Nov 2002 | |
| COLG34 | BOVESPA (Bolsa de Valores de Sao Paulo) | BDR EACH REPR 1 COM USD1 | BR | BRL | Sep 2011 |
Biography
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items. This segment markets and sells its products to various retailers, wholesalers, and distributors. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs; and a range of therapeutic products to manage disease conditions in dogs and cats. This segment markets and sells its products for dogs and cats through pet supply retailers, veterinarians, and e-commerce retailers. Its principal global and regional trademarks include Colgate, Palmolive, elmex, meridol, Tom’s of Maine, Sorriso, Hello, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sanex, Filorga, Elta MD, PCA Skin, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill’s Science Diet and Hill’s Prescription Diet. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2020/07/13 06:41 |
| End of Day Share Price | 2020/07/10 00:00 |
| Earnings | 2020/03/31 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.